Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Keep in mind OWCP is not based in the U.S.
Approximately 2 years from now the U.S. will be ramping up for a Presidential Election. I firmly believe this will be an item for one or both of the parties platform. People want it.
Meanwhile While we wait for the Fed's to pull their head out of the sand, we should be selling minimum 1 or 2 products in Europe and Canada. Possibly more.
Regardless, Im willing to wait. I added at .38 earlier in the week and will continue to do so while the funds are available and price is low.
Eventually the old Senators and Congressmen will move on an younger more open minded ones will replace them... It's only a matter of time IMO.
Edit
Haha just busting your chops. NP.
Hey!
I resemble that remark.lol
Hopefully it wont be too late and us staring at trips.
I assume the difference/ increase of 1.25 bil O.S. would have created some sort of cash flow.
Can you blame them....
I meant to imply , that I don’t believe there’s a conflict of interest due to the differences listed
Below are the cliff notes lol, note NTV is also using synthetic FDA approve composition...IMO there may be some legal ramifications seeing how JF is on OWCPs advisory board and insider....i
INTIVA’S DRUG DEVELOPMENT ACTIVITIES
?
INTIVA’s drug development strategy consists of:
??
the determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations;
conducting “freedom to operate” investigations on these conditions;
the preparation of patent applications and the prosecution of such application and/or the licensing of existing patents;
identifying the regulatory pathway with the U.S. Food and Drug Administration (FDA); and
proceeding with clinical studies and clinical trials under FDA protocols for submission to obtain approval for the drug(s).
?
Because of the federal illegality of cannabis in the United States, INTIVA is focusing its initial drug development using synthetic cannabinoids, some of which are approved by the FDA for various medical conditions.
?
Synthetic cannabinoids generally simplify research development in the U.S. However, INTIVA also intends to proceed with trials using plant-derived cannabinoids. Because of the difficulty in proceeding with those trials in the United States, the INTIVA will likely proceed with those trials in jurisdictions where the research is legal, such as Israel.
?
INTIVA’S DRUG DEVELOPMENT ACTIVITIES
?
INTIVA is researching the use of cannabinoid receptor modulators, terpenes, and other ingredients for:
?
The acute treatment during exposure to organophosphorus nerve agents , \including sarin gas.
The treatment of various symptoms related to myotonic and muscular diseases such as dystrophia diseases.
The treatment of various symptoms related to ipidosis, which are genetic disorders which are characterized by defects of the digestive system that impair the way the body uses dietary fat.
The treatment of various symptoms related to lipofuscinosis, in particular neural ceroid lipofuscinosis and macular degeneration associated with lipofuscinosis, which is any disorder associated with the abnormal storage of lipofuscins. Lipofuscins is a yellow to brownish pigment granule found in the muscle, heart, liver, kidney, adrenal, retina and nerve cells undergoing slow regressive changes and accumulating in lysomes with age.
The treatment of restless legs syndrome. Restless leg syndrome (RLS) otherwise known as Willis-Ekbom Disease and Wittmaack-Ekbom Syndrome is a term used to describe a neurological sensory disorder that also interferes with sleep and is thus also considered a sleep disorder.
Sexual health affecting both males and females. Male sexual health issues or dysfunction issues include male erectile dysfunction, ejaculatory disorders, such as premature ejaculation, anorgasmia (inability to achieve orgasm) and desire disorders such as hypoactive sexual desire disorder (lack of interest in sex). Female sexual health issues or dysfunction issues can be defined as the difficulty or inability of a woman to find satisfaction in sexual expression.
? The anti nerve agent could be a candidate for orphan drug status. The only similarity I see is the last paragraph regarding male sexual dysfunction. Different delivery mechanisms are probably used/ OWs condom and possibly synthetic cannaboids
IMO
I also look forward to your opinion of the presentation both here and OWc....
just attending the Conference is encouraging (not to mention as a Platinum Sponsor) and will bring more more eyes to NTVA
Just waiting for that little bit of news...
was that your 100k at .38?
Edit: Good call BTW
good to see your still holding, I see dbuss is as well.
thought you bailed....
Thanks Dawg!
Can one of the mods sticky note the recent 8K or post 17950?
edit post number
Im thankful for what I own...it appears we'll do pretty well once news hits.
Heck it's doing good without news and holding it's price.
I regret not buying more at those prices
Ditto Brother!
Hopefully so.
At this point I’m happy to see the update, now if we can only keep the tiny wheels turning..
On a serious note I recall a broken link on the Lppi website a few years back regarding residential housing.
Does anyone have any recollection of the project ?
I assumed your project was one mentioned in the 8k today.
January 19, 2018
LEEP Inc
CEO Delivers an Update to Shareholders
Louisville, KY.
LEEP Inc. OTC:LPPI the Company
Dear Shareholders and Investors.
We indicated in our last filing that the Company is pursuing domestic opportunities as well as continuing to focus on solutions for the US military and the US Department of State.
To that end we have been working with several companies in the design and costing of various residential solutions for affordable housing in specific locations in cities the southwest and western regions of the United States. These projects are aimed at high volume production of energy efficient, long term sustainable, affordable housing for rental and purchase.
We anticipate beginning order activity in the first quarter as proof of concept units are then built.
Our customer has agreed to be a sales agent for the Company in that area of the country.
We are also continuing to work on the prototype housing solution for the emerging market we referenced in our last communication, and added a similar opportunity in another foreign market.
We are currently in discussions with another sales agent to represent us in India and Eastern Africa in the warehousing and affordable housing markets.
The company has recently completed construction of its first Tiny Home for a western based customer who is interested in ordering additional ongoing units for resale, and representing the Company in that market niche. The first unit was constructed by the Company on wheels so it is mobile. It can also be converted to a non-mobile configuration if desired by the ultimate owner.
It is expandable to accommodate growing needs, and of course, has all the advantages of having been built out of the LeepCore panels, including R25 insulation, hurricane and seismic rated strength, mold, mildew, pest and rodent resistance, to name a few.
Our customer is targeting millenials, as well as others, for sales of these units and will work with their customers with a variety of designs as they ramp up their marketing effort.
In addition, engineering is in the final stages for a modern two story residence in the western USA that will be used as a prototype and marketing model for future home sales. Construction is slated for this Spring.
The Company continues to bid on, construct and secure outbuildings for the U.S. Department of State.
Based upon the current administration focusing on the safety and wellbeing of our citizens and military both here and abroad.
We anticipate that business will continue. USA Embassies are being remodeled, reconfigured, and in some cases relocated.
We also continue to focus on strategic solutions for the military, as well as more permanent housing solutions.
We will keep you updated on the progress related to projects above. Once again, we appreciate the faith and support of our loyal shareholder base, and look forward to being able to report positive developments in the future. We wish everyone a happy, healthy, and productive New Year.
With Best Regards,
John H. Nordstrom
CEO, LEEP Inc,
email investorrelations@leepinc.com
website www.leepinc.com
About LEEP Inc
LEEP Inc (OTC: LPPI) is the creator and manufacturer of the LeepCore Steel SIP (structural insulated panel).
The revolutionary building material designed for the 21st Century. LeepCore is a galvanized steel skin, polyurethane foam core, load-bearing SIP that is used to construct walls, roofs and floors. LeepCore constructed buildings are stronger, lighter and quicker to erect than with traditional building materials.
Did you see the residential housing?
That's pretty nice.
Exactly.
People also have to remember how the Mgmt team is compensated..
wouldn't he have to file a form 4 if he sold?
Capital One was my first online broker. They charge an additional fee both ways on stocks under a dollar... Had to change B/C of this
If I was to open another, Etrade would probably be it..
I haven't heard too many complaints..
It must have changed, I did not have to request the OTC
There actually a pretty good platform. They offer free level 2 ( Trade Architect).
Gosh, I hope not, especially in your profession
Thank You for chiming in on Tommy's comment.
IMO you are the most loyal and committed shareholder.
You, Tommy, myself and Louisiana Man ( if still here) have been holding for close to 90-100 years between us
LMAO
You call the below "Fluff"?
LPPI Security Details
Share Structure
Market Value1 $7,870,667 a/o Jan 23, 2018
Authorized Shares 2,000,000,000 a/o Jan 19, 2018
Outstanding Shares 1,249,312,251 a/o Jan 19, 2018
-Restricted 216,670,173 a/o Jan 19, 2018
-Unrestricted 1,032,642,078 a/o Jan 19, 2018
Held at DTC 308,494,578 a/o Jan 19, 2018
Float Not Available
Par Value No Par Value
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
heck you cant even give us an address as to where our machine is or if we have inventory.
Nobody is asking for fluff..
Agreed DL. Decent volume as well.
Im not quite sure what you mean..
The game hasnt even started for OWCP...
Much better!
Your picture would look much better without the snow.
What a game!
The real point is, once we get to his break even number we will have already turned the corner... smh
I was using a bit of off color humor on this cold snowy winters day..